Genmab Reduces Fair Value of Minnesota Manufacturing Facility to Zero, Moves Sale into 2013 and Updates 2012 Guidance

Genmab Reduces Fair Value of Minnesota Manufacturing Facility to Zero, Moves Sale into 2013 and Updates 2012 Guidance

[at noodls] – Company Announcement Fair value of the manufacturing facility reduced to zero Non-cash impairment charge of DKK 331 million (USD 58 million) Sale now projected in Q1 2013, aggressive sales process proceeding … more

View todays social media effects on GENC

View the latest stocks trending across Twitter. Click to view dashboard

See who Gencor is hiring next, click here to view

Share this post